As healthcare institutions continue to manage growing patient volumes, aging populations, and increasing rates of chronic diseases, the role of advanced vascular access technologies is becoming more significant. Manufacturers are responding with innovations designed to improve catheter dwell time, reduce complications, and enhance patient outcomes.
According to Persistence Market Research, the global peripheral IV catheter market size is expected to be valued at US$5.1 billion in 2026 and projected to reach US$8.9 billion by 2033. Growth is being propelled by the rise in global surgical volumes, increasing hospitalization rates, and intensifying regulatory focus on needlestick injury prevention, which mandates the adoption of safety-engineered IV access devices.
Increasing Hospitalizations Are Driving Demand for Reliable Vascular Access
Healthcare providers across the world are witnessing sustained growth in-patient admissions, particularly among elderly populations and individuals requiring long-term therapies. According to the World Health Organization (WHO), people aged 60 years and older are expected to reach 2.1 billion globally by 2050, compared with 1 billion in 2020. An aging demographic is highly susceptible to chronic illnesses, frequent hospital visits, and repeated intravenous treatments.
The U.S. Centers for Disease Control and Prevention (CDC) estimates that six in ten adults in the United States live with at least one chronic disease, while four in ten adults suffer from two or more chronic conditions. This shift is increasing demand for peripheral intravenous catheters that can remain functional for longer periods while minimizing discomfort for patients.
A patient receiving chemotherapy, antibiotic treatment, or hydration therapy often undergoes multiple cannulations during a hospital stay. Hospitals are hence looking for catheter technologies that can reduce insertion attempts and improve patient experiences. This growing focus on efficiency is encouraging healthcare providers to adopt advanced catheter stabilization systems and integrated safety features.
Infection Prevention Efforts Are Encouraging Technology Innovation
Hospital-acquired infections remain a major concern for healthcare institutions worldwide. Catheter-related complications such as phlebitis, infiltration, occlusion, and bloodstream infections can increase healthcare costs and prolong hospital stays.
According to the CDC, approximately one in every 31 hospitalized patients in the United States experiences at least one healthcare-associated infection on any given day. This statistic explains why hospitals are moving beyond conventional catheter products and investing in devices designed to improve safety.
Manufacturers are introducing antimicrobial coatings, blood control technologies, and closed-system catheter designs to lower contamination risks. These innovations not only help improve patient outcomes but also support healthcare facilities in achieving quality performance benchmarks. The impact extends beyond infection reduction. Hospitals are also seeking products that lower replacement frequency, reduce nursing workload, and optimize resource utilization.
Product Development is Helping Companies Differentiate Their Portfolios
Competition in the peripheral intravenous catheter market is now centered on product performance and patient comfort. Companies are developing catheters with integrated extension sets, passive safety mechanisms, and advanced securement technologies to reduce accidental dislodgement.
- In December 2025, BD Indonesia launched the BD Nexiva Closed IV Catheter System in Jakarta through the Vascular Access Management National Webinar. The hybrid event brought together approximately 1,100 healthcare professionals through onsite participation, satellite connections, and virtual platforms. BD organized the webinar to promote discussions on vascular access management and encourage the adoption of standardized intravenous therapy practices across Indonesia.
The aforementioned development indicates a broad industry transition from standard consumables toward value-added vascular access solutions. As healthcare providers prioritize safety, workflow efficiency, and patient outcomes, continued product innovation is expected to strengthen competitive positioning and support the rising adoption of advanced peripheral intravenous catheters.
Why Regulatory Expectations Are Becoming More Important for Healthcare Providers?
Regulatory standards surrounding vascular access devices continue to evolve, particularly in developed healthcare markets. Organizations such as the U.S. Food and Drug Administration (FDA) and infection prevention agencies emphasize device safety, biocompatibility, and adherence to best practices.
Hospitals are now adopting catheter management protocols because complications associated with intravenous therapy can contribute to additional treatment expenses and extended patient stays. This matters for healthcare providers as reducing catheter failure rates can lead to improved operational efficiency and better patient satisfaction scores.
From a manufacturer’s perspective, compliance with evolving regulations is becoming a competitive advantage. Companies capable of demonstrating superior clinical performance through research and real-world evidence are likely to strengthen their market position over time.
Sustainability is Emerging as a Consideration in Medical Device Manufacturing
Sustainability discussions have gradually expanded into the healthcare industry, including disposable medical devices. Peripheral intravenous catheters are typically designed for single-use applications to maintain sterility and patient safety. Hospitals are simultaneously seeking ways to reduce medical waste and improve procurement practices. Manufacturers are evaluating recyclable packaging materials, optimized production processes, and supply chain efficiencies to lower environmental impacts. For example,
- In September 2024, B. Braun Medical received the U.S. FDA clearance for its Introcan Safety 2 Deep Access IV Catheter. The product incorporates passive needlestick protection and blood control technology, helping clinicians manage patients with difficult venous access.
Although patient safety remains the primary priority, environmental considerations are expected to influence future innovation strategies. As healthcare settings continue balancing clinical performance with environmental responsibility, manufacturers that integrate sustainable manufacturing practices alongside product development are predicted to strengthen their long-term market competitiveness.
Recent Developments Reflect Changing Priorities Across Healthcare Settings
The peripheral intravenous catheter market is witnessing a shift toward advanced vascular access solutions that emphasize patient safety, clinical efficiency, and improved treatment outcomes. Manufacturers are introducing next-generation catheter stabilization systems, securement technologies, and digitally enabled monitoring solutions to reduce catheter failure and enhance clinical performance. In May 2025, healthcare technology providers showcased next-generation catheter stabilization systems designed to reduce catheter failure and improve securement outcomes during clinical conferences and hospital demonstrations.
Medical device companies are also strengthening partnerships with healthcare institutions to gather clinical evidence supporting product adoption decisions. Digital healthcare trends are creating opportunities for smart monitoring technologies capable of supporting catheter maintenance and reducing unnecessary replacements. These initiatives highlight how manufacturers are moving beyond product supply models toward comprehensive vascular access management solutions.
Future Perspective of the Peripheral Intravenous Catheter Market
The peripheral intravenous catheter market is entering a phase where innovation extends well beyond basic vascular access. Manufacturers are combining unique device design with digital technologies, clinical evidence, and sustainability initiatives to deliver solutions that address the evolving priorities of healthcare systems. As hospitals continue to emphasize quality care, standardized clinical practices, and resource optimization, next-generation peripheral IV catheters are projected to play an important role in improving treatment delivery and supporting long-term healthcare efficiency.
